세계의 혈액 처리용 소모품 시장 : 제품별, 용도별 예측(2025-2030년)

The Blood Processing Disposables Market was valued at USD 11.46 billion in 2023, expected to reach USD 12.69 billion in 2024, and is projected to grow at a CAGR of 10.75%, to USD 23.43 billion by 2030.

Blood processing disposables encompass a range of products designed for collecting, processing, storing, and transfusing blood and its components safely and efficiently. These include collection bags, filters, lancets, and tubing sets, which are integral in diagnostic and therapeutic interventions in hospitals, blood banks, and laboratories. The necessity of these products arises from the increasing demand for blood transfusions, spurred by rising surgical procedures, trauma cases, and blood disorders like anemia. Application-wise, they are crucial in separating blood components for various medical uses, ensuring sterility, safety, and efficiency in handling blood products. The end-use scope extends to healthcare settings, research facilities, and standalone blood donation camps, emphasizing their indispensability in health infrastructure.

Key market growth factors include advancing healthcare infrastructure, the prevalence of chronic diseases, and innovations in blood safety technologies. Latest opportunities are driven by evolving healthcare demands and investments in emerging markets, emphasizing the need for improved and cost-effective disposables. Companies can capitalize on these by enhancing R&D towards automated blood processing systems and integrating digital tracking solutions for better management and traceability. However, limitations exist in stringent regulatory approvals and issues surrounding the environmental impact of disposables, necessitating innovation in eco-friendly materials and waste management solutions.

Moreover, challenges such as high costs, limited access in low-income regions, and supply chain disruptions during pandemics (like COVID-19) affect market dynamics. Innovative areas for growth could include developing multi-functional disposables with real-time monitoring capabilities and leveraging AI to predict blood demand accurately. The nature of the market is competitive yet promising, underscored by a growing focus on improving patient safety and managing blood resources effectively. Enterprises poised to leverage these insights with agile strategies and collaborations can capture significant market share, proliferating their impact across healthcare sectors globally.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Processing Disposables Market

The Blood Processing Disposables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of infectious diseases and the rising need for blood collection
  • Increasing voluntary blood donation campaigns
  • Growing upgradations in healthcare policies promoting blood transfusion safety
• Market Restraints
  • Risk of contamination and transmission of diseases through transfusion
• Market Opportunities
  • Investments in R&D to produce high-tech disposables
  • Development of eco-friendly disposables with adoption of greener manufacturing processes
• Market Challenges
  • Issues of product recalls for disposable blood processing products

Porter's Five Forces: A Strategic Tool for Navigating the Blood Processing Disposables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Processing Disposables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Processing Disposables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Processing Disposables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Processing Disposables Market

A detailed market share analysis in the Blood Processing Disposables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Processing Disposables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Processing Disposables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Processing Disposables Market

A strategic analysis of the Blood Processing Disposables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Processing Disposables Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advin Health Care, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BIO-X, Cardinal Health, Inc., Fresenius Kabi AG, GE HealthCare Technologies Inc., Grifols, S.A., Haemonetics Corporation, Kawasumi Laboratories, Inc., Labtech Disposables, Maco Pharma SAS, Medtronic plc, Merck KGaA, Narang Medical Limited, Qiagen N.V., SARSTEDT AG & Co., Siemens Healthineers AG, TERUMO BCT, INC., Terumo Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Processing Disposables Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Administration Sets, Blood Bags, Blood Collection Needles, Blood Collection Tubes, Blood Filters, Blood Lancets, Coagulation Reagents, Hematology Reagents, Microscopic Slides, Sedimentation Tubes, Slide Stainers, Test Tube Racks, and Vials.
• Based on End-Use, market is studied across Academic Institutes, Blood Banks, Clinics, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of infectious diseases and the rising need for blood collection
    • 5.1.1.2. Increasing voluntary blood donation campaigns
    • 5.1.1.3. Growing upgradations in healthcare policies promoting blood transfusion safety
  • 5.1.2. Restraints
    • 5.1.2.1. Risk of contamination and transmission of diseases through transfusion
  • 5.1.3. Opportunities
    • 5.1.3.1. Investments in R&D to produce high-tech disposables
    • 5.1.3.2. Development of eco-friendly disposables with adoption of greener manufacturing processes
  • 5.1.4. Challenges
    • 5.1.4.1. Issues of product recalls for disposable blood processing products
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising use of blood collection tubes owing to their critical role in diagnostics and patient care
  • 5.2.2. End-Use: Growing need for blood processing disposables in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Processing Disposables Market, by Product

• 6.1. Introduction
• 6.2. Blood Administration Sets
• 6.3. Blood Bags
• 6.4. Blood Collection Needles
• 6.5. Blood Collection Tubes
• 6.6. Blood Filters
• 6.7. Blood Lancets
• 6.8. Coagulation Reagents
• 6.9. Hematology Reagents
• 6.10. Microscopic Slides
• 6.11. Sedimentation Tubes
• 6.12. Slide Stainers
• 6.13. Test Tube Racks
• 6.14. Vials

7. Blood Processing Disposables Market, by End-Use

• 7.1. Introduction
• 7.2. Academic Institutes
• 7.3. Blood Banks
• 7.4. Clinics
• 7.5. Diagnostic Centers
• 7.6. Hospitals

8. Americas Blood Processing Disposables Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Blood Processing Disposables Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Blood Processing Disposables Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Cml Biotech Installed an Integrated Blood Collection Tube Manufacturing Machine
  • 11.3.2. DBT Institute Develops Novel Bags To Increase Shelf Life Of Blood
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Advin Health Care
• 4. Beckman Coulter, Inc.
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. BIO-X
• 8. Cardinal Health, Inc.
• 9. Fresenius Kabi AG
• 10. GE HealthCare Technologies Inc.
• 11. Grifols, S.A.
• 12. Haemonetics Corporation
• 13. Kawasumi Laboratories, Inc.
• 14. Labtech Disposables
• 15. Maco Pharma SAS
• 16. Medtronic plc
• 17. Merck KGaA
• 18. Narang Medical Limited
• 19. Qiagen N.V.
• 20. SARSTEDT AG & Co.
• 21. Siemens Healthineers AG
• 22. TERUMO BCT, INC.
• 23. Terumo Corporation
• 24. Thermo Fisher Scientific Inc.